Epcoritamab plus R² in follicular lymphoma: practice-changing efficacy meets unresolved toxicity trade-offs. [PDF]
Ke Q, Zhou S.
europepmc +1 more source
Towards a chemo-free approach for follicular lymphoma. [PDF]
Luminari S, Barbieri E, Nizzoli ME.
europepmc +1 more source
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study. [PDF]
Cheah CY +11 more
europepmc +1 more source
CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma. [PDF]
Canichella M +4 more
europepmc +1 more source
Chemotherapy-Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune-Based Approaches. [PDF]
Martino EA +12 more
europepmc +1 more source
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis. [PDF]
Bartlett NL +20 more
europepmc +1 more source
Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis. [PDF]
Shen J +7 more
europepmc +1 more source
Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated With a Follicular Lymphoma in a Ring-tailed Lemur (Lemur catta). [PDF]
Aradilla N +7 more
europepmc +1 more source
Aggressive Recurrent Bilateral Chylothorax Secondary to Follicular Lymphoma in an HIV-Positive Patient: A Case Report and Clinical Implications. [PDF]
Jagra AS +4 more
europepmc +1 more source

